NTAGI Archives

Home>>NTAGI

Covovax Review: NTAGI’s Working Group To Review New Serum Vaccine

Gunjan ChaudharyMarch 30, 20220

The COVID-19 working group of the National Technical Advisor (NTAGI) will review the new corona vaccine 'Covovax' developed by the Serum Institute of India (SII). This vaccine is designed for children and adults specifically. And the review meeting will be held on April 1. The NTAGI set up for Immunization has a three-tier system to decide on a vaccine. This working group is of the first level review. A second-level Standing Technical Sub-Committee (STSC) will review and discuss the safety and effectiveness of the vaccine data after the working group looks at the safety and effectiveness of the vaccine data. Thereafter, STSC will give its decision to the third group to make the final decision. Booster Dose Is Not For Everyone In the meeting to be held on Friday, NTAGI will not discu...

COVID-19EducationForce MajeureHealthHotIndiaLatest NewsLifestyleScience & TechSocietyTrendingVaccine

Covishield Shots Gap Reduced Amid COVID-19 Surge In Asia, Europe

Sonia SolankiMarch 21, 20220

The National Technical Advisory Group on Immunization (NTAGI) plans to cut down the gap between the two shots of Covishield. This recommendation by NTAGI pours in as the Omicron surge is making news in Asia and Europe during last week. The World Health Organisation (WHO) chief recently warned people that this could be the "tip of the iceberg." Why Covishield Gap Cutdown? Talking of the upcoming surge of Omicron 2 in Asia, India continues to curb the number of covid infections. This is a great relief but we still need to understand that the coronavirus new variants are still in circulation. Vaccination cover is yet to reach each and every eligible candidate. Social distancing and wearing mask is also reducing as day by day social activity are becoming rigorous. Secondly, India h...